Archivo de la etiqueta: Research

¿Diferentes formas de EMPP?:Síntomas y tratamientos.

Representan entre el 10% y el 20% de los casos totales de esclerosis múltiple en el mundo, desde el inicio la discapacidad se acumula y las opciones de tratamiento son muy escasas. Pero algo está cambiando.

Las personas con esclerosis múltiple primaria progresiva,  paradójicamente,  tienen menos lesiones cerebrales, pero más discapacidad ¿Por qué? Seguir leyendo ¿Diferentes formas de EMPP?:Síntomas y tratamientos.

Gran estudio de Alzheimer encuentra nuevos genes asociados con la enfermedad y EM

English: PET scan of a human brain with Alzhei...

Nuevos genes relacionados con aparición tardía de Alzheimer se han descubierto, dando a los científicos pistas sobre cómo crear mejores medicamentos para combatir la enfermedad. Los investigadores de las multinacionales Genómica Internacionales de Proyecto de Alzheimer (IGAP) han descubierto 11 genes que amplían nuestra comprensión de la enfermedad  confirman su solapamiento con otras enfermedades neurodegenerativas como el Parkinson y la esclerosis múltiple. Seguir leyendo Gran estudio de Alzheimer encuentra nuevos genes asociados con la enfermedad y EM

Medical breakthrough for multiple sclerosis sufferers

NewBrain_640

In a breakthrough discovery, researchers have discovered a treatment capable of reducing the debilitating autoimmune response that occurs in people suffering from multiple sclerosis (MS).

When patients are diagnosed with multiple sclerosis, their bodies begin to attack the protein myelin, which insulates the body’s spinal cord, brain and optic nerves. As a result, MS patients experience symptoms such as numbness in their limbs, paralysis and sometimes blindness.

However, during a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body’s attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system. Seguir leyendo Medical breakthrough for multiple sclerosis sufferers

Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients

English: Recreated :File:Neuron-no labels2.png...

Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients

Grau-López et al. BMC Neurology 2012, 12:103
http://www.biomedcentral.com/1471-2377/12/103

We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes

 

Types of MS

We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes

Multiple Sclerosis Journal

Relapsing−remitting and primary progressive MS have the same cause(s) 2

 

English: Cervical spine MRI with enhancement s...

Relapsing−remitting and primary progressive MS have the same cause(s)- the neuropathologist’s

Multiple Sclerosis Journal

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

 

English: Recreated :File:Neuron-no labels2.png...

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

Multiple Sclerosis Journal

$18 Million In New Research Projects Launched To Stop Multiple Sclerosis

 

English: Cervical spine MRI with enhancement s...

$18 Million In New Research Projects Launched To Stop Multiple Sclerosis

NEW YORK, April 16, 2013 /PRNewswire-USNewswire/ — The National Multiple Sclerosis Society has committed another $18 million to support up to 65 new MS research projects. These new awards are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever. 

CU Researchers Hope To Find Keys To Pediatric MS

CU Researchers Hope To Find Keys To Pediatric MS

As many as 10,000 children suffer from multiple sclerosis. Now researchers around the nation have begun a study to find what in their environments and genetics may have triggered a disease at a young age.